Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial

Radiology Imaging Cancer 2026 Open access

Read full text
Authors: Luigi Nardone, Elif Öcal, Lukas Salvermoser, Matthias Philipp Fabritius, Daniel Puhr‐Westerheide, Matthias Stechele, Stefanie Corradini, Jens Ricke, Moritz Wildgruber, Marianna Alunni‐Fabbroni, Max Seidensticker
DOI: 10.1148/rycan.250685
Cited by: 1
References: 34

Abstract

A circulating three-protein panel predicted response and survival after liver ablation across patients with primary and metastatic cancers, providing a novel tool to refine patient selection for liver-directed therapies.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Research and Treatments Liver Disease Diagnosis and Treatment

Publication details

Journal / source
Radiology Imaging Cancer
Publisher
Radiological Society of North America (RSNA)
Volume
8
Issue
4
Pages
e250685–e250685
Publication date
1 July 2026
Language
EN